Authors/Disclosures
		
			| Christopher J. Klein, MD, FAAN
					(Mayo Clinic) | Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. | 
		
			|  | No disclosure on file | 
		
			| Christopher M. DeGiorgio, MD, FAAN
					(UCLA Department of Neurology At Olive View) | Dr. DeGiorgio has received intellectual property interests from a discovery or technology relating to health care. | 
		
			| Sean J. Pittock, MD, FAAN
					(Mayo Clinic Dept of Neurology) | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics.  The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys.  The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.  The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech.  The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka.  The institution of Dr. Pittock has received research support from NIH.  The institution of Dr. Pittock has received research support from Alexion/AstraZeneka.  The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			| JaNean Engelstad | JaNean Engelstad has nothing to disclose. | 
		
			|  | No disclosure on file | 
		
			| Sean Taylor, MD
					(Dalhousie University & Nova Scotia Health Authority) | No disclosure on file | 
		
			| Peter J. Dyck, MD, FAAN
					(Mayo Clinic) | Dr. Dyck has nothing to disclose. | 
		
			| John L. Berk | John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio. |